MIA takes centre stage at leading cancer conference
5 June 2019
Researchers from Melanoma Institute Australia (MIA) took centre stage at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, attended by over 40,000 professionals. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Four independent presentations on melanoma
“Four presentations from one institution, including a Clinical Science Symposium,
Dr Da Silva’s research is paving the way for personalised therapies, as she unveiled a detailed analysis of melanoma biomarkers to predict treatment response.
“These outliers are so important to our research. These are the patients who can teach us about resistance or conversion to therapy, which is our next big research focus,” said Professor Richard Scolyer, Co-Medical Director of MIA.
Another MIA presentation outlined what researchers hope will be the new benchmark for drug testing and regulatory approval. MIA’s Associate Professor Alex Menzies presented analyses of data from six
MIA medical oncology fellow Dr Carina Owen presented the analysis from her study looking at international data of patients who recur on adjuvant immunotherapy (immunotherapy given after surgical intervention). Her analysis reveals that patients who recur after stopping treatment early or completing their therapy may respond to further immunotherapy.
Professor Angela Hong also presented the results from MIA’s whole brain radiotherapy (WBRT) trial. The international Phase III trial found that WBRT does not prolong overall survival compared to observation. As WBRT can be morbid, using this information as the foundation for treatment changes will improve the quality of life for patients whose melanoma has spread to the brain.
In the melanoma and skin cancer poster session, MIA was again well-represented with six posters on display. Professor Long presented two posters summarising new and further results from clinical trials. The newest cohort of patients on the Keynote-029 study have
A poster by Dr
Associate Professor Matt Carlino presented the outline of a new clinical trial, where giving patients with resected Stage II melanoma adjuvant
“We’re exceptionally proud of our ASCO presenters. Each one is pushing forward the treatment landscape for our patients and edging closer to our goal of zero deaths from melanoma,” said Professor Long.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play
This week, Melanoma Institute Australia hosted the first of six
Federal government urged
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in